Zydus Lifesciences has secured US FDA approval to manufacture Lidocaine, Prilocaine Cream.

Zydus Lifesciences, a leading Indian pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) to manufacture Lidocaine and Prilocaine Cream. This cream is used for topical anesthesia, pain relief, and numbing of the skin before minor surgical procedures. The approval allows Zydus Lifesciences to manufacture and supply the cream to the US market, making it the first Indian company to receive this approval. The company’s USFDA-approved facility in Ahmedabad, Gujarat, will produce the cream, which will be exported to the US. This approval is a significant milestone for Zydus Lifesciences, demonstrating its capabilities and compliance with global regulatory standards. The company’s presence in the US market will provide a new revenue stream and expand its global footprint.